Skip to main content

Closing Bell: Biosyent Inc down on Friday (RX)

Automated Summaries - The Globe and Mail - Mon Aug 5, 4:01PM CDT

Biosyent Inc opened trading today at $10.21 and closed at $10.09. prices ranged from a low of $9.90 to a high of $10.21.

The price eased -1.08 percent from the previous day's close of $10.20.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 9,710 on 17 total trades, with an average volume of 8,142 over 5 days.

The TSX-V overall saw 432 price advancers against 4,843 declines and 43 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.55 (August 08,2023). Moreover, the shares have boosted 32.76 percent in the last 52 weeks, while they have advanced 9.44% year-to-date.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $116.89 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..